Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Grålum
Clinical trial register · Norway

Clinical Trials in Grålum, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Norway and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1259 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1259
Studies in scope
all four open statuses
666
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
Oslo 727 Bergen 323 Trondheim 255 Tromsø 148 Stavanger 123
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Akershus3 Bristol-Myers Squibb3 AstraZeneca2 Takeda2 Ostfold Hospital Trust2 Merck Sharp & Dohme LLC2 Oslo University Hospital2 Boehringer Ingelheim2 Sahlgrenska University Hospital1 Ribocure Pharmaceuticals AB1 Helsinki University Central Hospital1 CSL Behring1 Sykehuset Telemark1 Norwegian University of Science and Technology1 Pfizer1 University of Southern California1 Guri Hagberg1 Eli Lilly and Company1 Novartis Pharmaceuticals1 Vestre Viken Hospital Trust1 AbbVie1 Nordic Lymphoma Group1
Site location
Oslo727 Bergen323 Trondheim255 Tromsø148 Stavanger123 Lørenskog101 Drammen94 Kristiansand58 Ålesund56 Bodø38 Tønsberg35 Grålum32 Lorenskog26 Arendal26 Haugesund24 Gjøvik24 Skien22 Levanger22 Lillehammer17 Førde16 Sarpsborg15 Hamar14 Nordbyhagen12 Fredrikstad11 Molde11 Show all 113
All 113 locations
Target enrolment
to

Trials with a site in Grålum

32 of 1259 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Norway
Start
Not yet open
Sahlgrenska University Hospital
Phase 4
400
Bergen, Drammen, Grålum, Lörenskog, Oslo, Stavanger
2026-12-01
Not yet open
Vortosiran in Atrial Fibrillation
NCT07870889Non-valvular Atrial Fibrillation (AF)
DrugsVortosiran·Apixaban
Ribocure Pharmaceuticals AB
Phase 2
150
Grålum, Lørenskog
2026-10-01
Recruiting
AstraZeneca
Phase 3
7,000
Bergen, Bodø, Drammen, Grålum, Haugesund, Levanger, Lørenskog, Oslo
2026-08-21
Recruiting
University Hospital, Akershus
Phase 4
1,900
Bergen, Oslo, Trondheim, Ålesund, Bodø, Drammen, Gjettum, Grålum
2026-04-23
Recruiting
Bristol-Myers Squibb
Phase 3
750
Grålum, Drammen
2026-03-12
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Bergen, Grålum, Stavanger
2026-02-17
Recruiting
University of Southern California
Not applicable
600
Grålum
2026-01-23
Recruiting
Eli Lilly and Company
Phase 1/2
68
Bergen, Grålum, Trondheim
2025-07-30
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Arendal, Bodø, Drammen, Grålum, Lørenskog, Oslo, Skedsmokorset, Stavanger
2025-07-22
Recruiting
Takeda
Phase 3
347
Lorenskog, Tønsberg, Bergen, Grålum, Stavanger, Trondheim
2025-07-15
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Bodø, Grålum, Oslo, Trondheim
2025-06-10
Recruiting
Oslo University Hospital
Phase 3
450
Grålum, Kristiansand, Lillehammer, Oslo, Skien, Trondheim
2025-06-06
Recruiting
Thrombolysis in Factor Xa-inhibitors Trial
NCT06878066Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke, Acute Ischemic Stroke
DrugsAlteplase·Tenecteplase
Guri Hagberg
Phase 3
300
Baerum, Ålesund, Bergen, Drammen, Grålum, Kristiansand, Lillehammer, Oslo
2025-03-14
Recruiting
Takeda
Phase 3
171
Bergen, Grålum, Lorenskog
2025-02-27
Recruiting
University Hospital, Akershus
Not applicable
50
Oslo, Grålum
2025-01-02
Recruiting
Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial
NCT06333392Colorectal Neoplasia, Screening Colonoscopy, Colorectal Cancer, Colorectal Cancer Screening
Vestre Viken Hospital Trust
Not applicable
1,070
Drammen, Grålum, Lørenskog, Oslo
2024-10-23
Recruiting
The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures
NCT06568276Ankle Fractures, Deltoid Ligament; Sprain (Strain) (Ankle)
Ostfold Hospital Trust
Not applicable
120
Grålum, Ålesund, Bergen, Bodø, Elverum, Gjøvik, Levanger, Oslo
2024-09-20
Recruiting
CSL Behring
Phase 2/3
3,110
Drammen, Grålum, Skien
2024-04-27
Recruiting
Norwegian University of Science and Technology
Not applicable
100
Ålesund, Bergen, Drammen, Grålum, Hamar, Kristiansand, Oslo, Stavanger
2024-01-01
Active, closed
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU
Helsinki University Central Hospital
Not applicable
3,500
Arendal, Grålum, Oslo, Stavanger
2023-08-17
Active, closed
Bristol-Myers Squibb
Phase 3
579
Bodø, Grålum, Lørenskog, Oslo
2023-03-06
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Grålum
2023-02-03
Recruiting
Antibiotic Therapy in Viral Airway Infections
NCT05045612Infectious Disease, Influenza, Respiratory Syncytial Virus (RSV), Respiratory Tract Infections
University Hospital, Akershus
Phase 4
380
Bergen, Drammen, Gjettum, Grålum, Kristiansand, Lørenskog, Oslo, Skien
2022-01-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Lorenskog, Kristiansand, Bergen, Trondheim, Oslo, Grålum
2021-04-14
Recruiting
Treatment of Fifth Metatarsal Zone 3 Fractures
NCT04847115Fractures, Stress, Metatarsal Fracture
Ostfold Hospital Trust
Not applicable
100
Grålum, Lørenskog, Oslo
2021-04-10
Active, closed
Treatment of Olecranon Fractures in the Elderly
NCT04670900Olecranon Fracture
Oslo University Hospital
Not applicable
76
Sandvika, Hønefoss, Trondheim, Arendal, Bergen, Grålum, Oslo, Skien
2021-03-22
Recruiting
Nordic Lymphoma Group
Phase 3
300
Bergen, Grålum, Innlandet, Oslo, Stavanger, Trondheim, Tønsberg
2020-08-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Lorenskog, Drammen, Stavanger, Oslo, Grålum
2020-07-06
Active, closed
Bristol-Myers Squibb
Phase 3
790
Bergen, Grålum, Oslo
2019-10-28
Recruiting
Genetic Study of Amyotrophic Lateral Sclerosis in Norway
NCT05119387Amyotrophic Lateral Sclerosis
Sykehuset Telemark
Observational
1,200
Bergen, Bodø, Drammen, Førde, Grålum, Haugesund, Kristiansand, Lillehammer
2019-08-01
Active, closed
Pfizer
Phase 3
1,054
Grålum, Lorenskog, Oslo, Trondheim
2017-12-18
Active, closed
AbbVie
Phase 3
443
Nordlenangen, Drammen, Bergen, Grålum
2017-02-02
Rows per page Showing 1–32 of 32
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Norwegian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-norway/city/gr-lum

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Norway and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,259 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 32 of those studies with a site in Grålum.

How many clinical trials are recruiting in Grålum?

20 of the 32 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Grålum), 32 studies
PhaseStudiesRecruitingShare
Phase 317953.1%
Not applicable8625%
Phase 4329.4%
Observational113.1%
Phase 1/2113.1%
Phase 2103.1%
Phase 2/3113.1%

Most active sponsors

Lead sponsors with the most studies (Grålum)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb31
University Hospital, Akershus33
AstraZeneca21
Boehringer Ingelheim22
Merck Sharp & Dohme LLC20
Oslo University Hospital21
Ostfold Hospital Trust22
Takeda22
AbbVie10
CSL Behring11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.